Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study

Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study

Immune checkpoint inhibitors (ICIs) have revolutionized metastatic melanoma treatment, but our knowledge of ICI activity across age groups is insufficient. Patients in different age groups with advanced melanoma were selected based on the ICI approval time in this study. Patients with melanoma were...

Full description

Bibliographic Details
Main Authors: Mohammed Safi, Mahmoud Al-Azab, Chenxing Jin, Dario Trapani, Salem Baldi, Salah Adlat, Aman Wang, Bashir Ahmad, Hamza Al-madani, Xiu Shan, Jiwei Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Immunology
Subjects:
age distribution
melanoma
SEER database
epidemiology
immune-checkpoint inhibitor (ICI)
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.609728/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.609728/full

Similar Items